Active10615288Private limited companyAddlestone

XPLORE PHARMA LTD

Significant control: Source Group International Ltd (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Xplore Pharma Ltd sell?

Registered activity: Temporary employment agency activities (SIC 78200). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

XPLORE PHARMA LTD is an active private limited company (company number 10615288) incorporated on 13 February 2017, registered in Addlestone. Its registered activity is temporary employment agency activities (SIC 78200). Latest dormant accounts cover the period ending 31 December 2024 and cash of £420, with 2 employees on average.

There are 1,117 companies in temporary employment agency activities in Greater London with filed accounts; the median reports net assets of £1,046 and is 7 years old.

02

Ownership and control

1 active · 2 other
  • Source Group International Ltd
    corporate entity, England · since 10 March 2020
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mr Lawrence Hargreaves
    Individual · since 13 February 2017 · ceased 10 March 2020
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Mr Gavin Tew
    Individual · since 13 February 2017 · ceased 10 March 2020
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
13 February 20179 yrs ago
Next accounts due
30 September 202623 days overdue
Confirmation statement due
27 February 2027in 127 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 78200
Temporary employment agency activities
Accounts type
Dormant
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
Not reported
Cash at bank
£420
No changevs Dec 2023
Turnover
Not reported
Employees
2
No changevs Dec 2023
Cash at bank
£420
Average employees
2
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024—£420£8,788£329k——2
31 December 2023—£420£8,788£329k——2
Current ratio0.03Current assets ÷ creditors within one year
Cash per employee£210Cash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Current assets below creditors within one yearCurrent ratio 0.03
  • Incorporated five or more years agoIncorporated 13 February 2017
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 127 days
  2. Next accounts due23 days overdue
  3. Accounts period end
  4. Accounts period end
  5. Incorporated
08

Similar companies in Greater London

Same activity (temporary employment agency activities), closest in incorporation date
09

Reminders for XPLORE PHARMA LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.